STOCK TITAN

HTG Molecular Diagnostics to Present at H.C. Wainwright’s 23rd Annual Global Investment Conference

HTG Molecular Diagnostics (Nasdaq: HTGM) announces participation in the H.C.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

HTG Molecular Diagnostics (Nasdaq: HTGM) announces participation in the H.C. Wainwright’s 23rd Annual Global Investment Conference from September 13-15, 2021. Management will present at 7:00 a.m. ET on September 13 and will be available for one-on-one meetings. This event underscores HTG's commitment to advancing precision medicine through its proprietary HTG EdgeSeq technology, which facilitates complex molecular profiling from both solid and liquid samples. Further details on the webcast and meeting requests can be found in the release.

Loading...
Loading translation...
Argus Session date unavailable
+2.14% session move Open Argus
Details

News Market Reaction – HTGM

The recorded move for HTGM in the trading session of this news was +2.14%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

TUCSON, Ariz., Sept. 08, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will participate in H.C. Wainwright’s 23rd Annual Global Investment Conference, being held September 13th – 15th, 2021.

Details for the presentation are below:

Date:7:00 a.m. ET
Time:Monday, September 13th, 2021
Webcast:https://journey.ct.events/view/36113800-95ac-4c91-b29a-d6ec60e0fddf

Management will also be available for 1x1 meetings. If you would like to request a meeting, please email meetings@hcwco.com.

About HTG:
HTG is focused on NGS-based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. Its mission is to empower precision medicine. To learn more, visit www.htgmolecular.com.

Contact:

Ashley Robinson
Phone: (617) 430-7577
Email: arr@lifesciadvisors.com 


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What event will HTG Molecular Diagnostics participate in September 2021?

HTG Molecular Diagnostics will participate in H.C. Wainwright’s 23rd Annual Global Investment Conference from September 13-15, 2021.

What is the date and time of HTG's presentation at the conference?

HTG's presentation at the conference is scheduled for 7:00 a.m. ET on September 13, 2021.

How can I access the webcast for HTG's presentation?

The webcast for HTG's presentation can be accessed through the provided link in the press release.

How can I request a 1x1 meeting with HTG management during the conference?

To request a 1x1 meeting with HTG management, you can email meetings@hcwco.com.

What technology does HTG use for molecular profiling?

HTG uses its proprietary HTG EdgeSeq technology for NGS-based molecular profiling from solid and liquid samples.

Keep reading